SETD2 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), SETD2-mediated H3K36me3 is essential for cytotoxicity to cisplatin through regulation of the extracellular signal-regulated kinase (ERK) signaling pathways89.